Motesin (Azelastine Hydrochloride, Fluticasone Propionate)

Azelastine hydrochloride blocks H1 histamine receptors in the nasal mucosa, preventing histamine from triggering the typical allergic responses such as itching, swelling, and increased mucus production. This action reduces the immediate symptoms of an allergic reaction.

The prescribed dose of Motesin is determined by the treating clinician based on the patient’s age, severity of symptoms, and overall health. The prescriber will provide specific instructions on the number of sprays per nostril and the frequency of administration.

Safety data for Motesin in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any possible risks before prescribing it to pregnant or nursing individuals. Patients should discuss their situation with a qualified medical professional.

To request Motesin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Motesin offers a dual mechanism by pairing an antihistamine (azelastine) with a corticosteroid (fluticasone), providing both rapid symptom relief and longer‑term anti‑inflammatory control. Single‑agent sprays may contain only one of these actions, potentially requiring additional medication for complete symptom management.

Motesin should be stored at room temperature, away from excessive heat and moisture. Keep the spray in its original container, protect it from direct sunlight, and ensure the cap is tightly closed when not in use to maintain product stability.

Motesin is administered as a nasal spray. The patient gently shakes the bottle, primes it if required, tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of actuations while breathing in gently. The process is then repeated for the other nostril if directed.

Serious risks, although uncommon, include nasal septal perforation, severe allergic reactions such as anaphylaxis, vision changes or increased intraocular pressure, and systemic effects from prolonged corticosteroid exposure like adrenal suppression. Any of these signs should prompt immediate medical evaluation.

Motesin should not be used by individuals with a known hypersensitivity to azelastine, fluticasone, or any of the formulation’s excipients. It is also contraindicated in patients who have had recent nasal surgery or trauma unless specifically advised by a healthcare professional.